CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss	Total
Balance, beginning of period at Dec. 31, 2023	$ 1,271,565	$ 312,450	$ (83,015)	$ 1,501,000
Balance, beginning of period (in shares) at Dec. 31, 2023	152,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(26,287)		(26,287)
Foreign currency translation adjustments			(6,683)	(6,683)
Settlement of convertible debt conversion	$ (84)			(84)
Repurchases of common stock	$ (5,032)			(5,032)
Repurchases of common stock (in shares)	(463)
Termination of capped calls	$ 4,381			4,381
Activity in company stock plans, net and other	$ (2,071)			(2,071)
Activity in company stock plans, net and other (in shares)	622
Share-based compensation	$ 1,598			1,598
Balance, end of period at Mar. 31, 2024	$ 1,270,357	286,163	(89,698)	1,466,822
Balance, end of period (in shares) at Mar. 31, 2024	152,450
Balance, beginning of period at Dec. 31, 2024	$ 1,252,253	368,087	(100,575)	1,519,765
Balance, beginning of period (in shares) at Dec. 31, 2024	150,243
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		3,072		3,072
Foreign currency translation adjustments			27,185	27,185
Activity in company stock plans, net and other	$ (6,279)			(6,279)
Activity in company stock plans, net and other (in shares)	1,287
Share-based compensation	$ 1,522			1,522
Balance, end of period at Mar. 31, 2025	$ 1,247,496	$ 371,159	$ (73,390)	$ 1,545,265
Balance, end of period (in shares) at Mar. 31, 2025	151,530